HMGB1 and Miyoshi myopathy: HMGB1 promotes human MM cell survival and proliferation via RAGE (Jube et al,2012), whereas BoxA, its N‐terminal fragment, acts as an HMGB1 competitor and antagonist on RAGE and TLR4 receptors (Venereau et al,2016).